Icon PLC (ICLR): Shareholders' Equity
$9.19B
As of 2025-12-31
+2.7%
3-year compound annual growth
+37.8%
5-year compound annual growth
+28.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.19B | -2.6% | 2026-05-27, Balance as of period end |
| 2024-12-31 | $9.44B | +2.5% | 2026-05-27, Balance as of period end |
| 2023-12-31 | $9.21B | +8.4% | 2026-05-27, Balance as of period end |
| 2022-12-31 | $8.50B | +5.3% | 2025-02-21, Balance as of period end |
| 2021-12-31 | $8.07B | +336.0% | 2024-02-23, Balance as of period end |
| 2020-12-31 | $1.85B | +14.3% | 2023-02-24, Balance as of period end |
| 2019-12-31 | $1.62B | +19.5% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $1.35B | +13.7% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $1.19B | +26.0% | 2020-02-27, Balance as of period end |
| 2016-12-31 | $945.17M | +23.9% | 2019-03-01, Balance as of period end |
| 2015-12-31 | $763.10M | -19.7% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $950.21M | +4.4% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $910.58M | +20.7% | 2016-03-23, Balance as of period end |
| 2012-12-31 | $754.58M | +10.7% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $681.54M | +1.7% | 2014-03-12, Balance as of period end |
| 2010-12-31 | $670.00M | +17.1% | 2013-03-06, Balance as of period end |
| 2009-12-31 | $572.25M | +25.4% | 2012-03-02, Balance as of period end |
| 2008-12-31 | $456.37M | n/a | 2011-03-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $9.19B | -2.6% |
| Incyte Corp (INCY) | 2025-12-31 | $5.17B | +49.9% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $6.63B | +9.3% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $3.17B | -8.6% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $459.07M | -44.4% |
| NRC Health (NRC) | 2025-12-31 | $13.99M | -55.3% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $171.49M | -16.9% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $267.03M | -7.2% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $11.14M | +109.3% |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗